Biotech · Private company · Doylestown, PA, US
Harlingene Life Sciences LLC
Track this companyFree. Adds Harlingene Life Sciences LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Hepatoselective Dihydrozuinolizone (HS-DHQ) Molecules for Treatment and Prevention of Hepatitis A Virus (HAV) InfectionFiscal year 2026 · $1MNIH RePORTER 5R42AI177204-04 · fetched Nov 12, 2026
- Hepatoselective Dihydrozuinolizone (HS-DHQ) Molecules for Treatment and Prevention of Hepatitis A Virus (HAV) InfectionFiscal year 2025 · $1MNIH RePORTER 2R42AI177204-03 · fetched Nov 12, 2026
- Hepatoselective Dihydroquinolizinone (HS-DHQ) Molecules for Treatment and Prevention of Hepatitis A Virus (HAV) InfectionFiscal year 2024 · $300KNIH RePORTER 5R41AI177204-02 · fetched Nov 12, 2026